Second Sight Medical Products Inc (EYES)

[zitry]

Sold all EYES before quarterly report between 1.01 and 1.02 because I expected exactly what I heard on the conference call. Kept EYESW and will add EYESW when the opportunity presents itself. Another offering as before will come Q1 2020. No support yet established so EYES could easily dip to last offering price of $.725. With a 40% gain and free EYESW shares it made no sense to hold now. It appears ORION approval is still probably at least a year away and SS has no intent to increase sales with current product line so financials will not improve. SS is all in on ORION. With ORION approval shares will skyrocket. I believe in EYES as a great company so it hurt to have to make this financial decision.